Octreotide in the treatment of gastrointestinal bleeding caused by angiodysplasia in two patients with von Willebrand's disease

Br J Haematol. 2000 Mar;108(3):524-7. doi: 10.1046/j.1365-2141.2000.01897.x.

Abstract

Two cases of von Willebrand's disease and angiodysplasia with intractable gastrointestinal bleeding are presented. Replacement therapy with cryoprecipitate and variable purity von Willebrand factor (VWF) was ineffective, as were other treatments including steroids, immunoglobulin and hormonal replacement. Both patients required massive blood transfusion and product support. The efficacy of somatostatin and an analogue is described. In one patient, we observed a rise in von Willebrand factor activity after octreotide infusion.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Angiodysplasia / drug therapy
  • Angiodysplasia / etiology*
  • Cost-Benefit Analysis
  • Drug Administration Schedule
  • Female
  • Gastrointestinal Hemorrhage / drug therapy*
  • Gastrointestinal Hemorrhage / etiology*
  • Hemostatics / economics
  • Hemostatics / therapeutic use*
  • Humans
  • Injections, Subcutaneous
  • Male
  • Middle Aged
  • Octreotide / economics
  • Octreotide / therapeutic use*
  • von Willebrand Diseases / complications*
  • von Willebrand Diseases / drug therapy

Substances

  • Hemostatics
  • Octreotide